Our studies have also shown that IL-33 is upregulated in the glia of neurodegenerative diseases such as in Alzheimer’s disease brain [45], and MPP+ induced IL-33 release from mouse astrocytes in vitro [68]. Here, IL33 is linked to Alzheimer disease.